Nkarta, Inc. (NKTX)
2.77
+0.02
(+0.73%)
USD |
NASDAQ |
Aug 28, 16:00
2.77
0.00 (0.00%)
After-Hours: 17:53
Nkarta Cash from Operations (Quarterly) : -24.22M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -24.22M |
| March 31, 2026 | -28.20M |
| December 31, 2025 | -21.65M |
| September 30, 2025 | -18.69M |
| June 30, 2025 | -18.75M |
| March 31, 2025 | -29.61M |
| December 31, 2024 | -24.75M |
| September 30, 2024 | -24.54M |
| June 30, 2024 | -21.89M |
| March 31, 2024 | -28.51M |
| December 31, 2023 | -23.35M |
| September 30, 2023 | -20.28M |
| June 30, 2023 | -21.77M |
| March 31, 2023 | -20.76M |
| December 31, 2022 | -7.331M |
| Date | Value |
|---|---|
| September 30, 2022 | -14.80M |
| June 30, 2022 | -16.61M |
| March 31, 2022 | -18.26M |
| December 31, 2021 | -17.57M |
| September 30, 2021 | -18.26M |
| June 30, 2021 | -17.45M |
| March 31, 2021 | -14.65M |
| December 31, 2020 | -12.85M |
| September 30, 2020 | -12.12M |
| June 30, 2020 | -10.24M |
| March 31, 2020 | -8.287M |
| December 31, 2019 | -6.636M |
| September 30, 2019 | -4.649M |
| June 30, 2019 | -3.265M |
| March 31, 2019 | -3.817M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 58.28M |
| Theriva Biologics, Inc. | -3.085M |
| Unicycive Therapeutics, Inc. | -7.604M |
| OnKure Therapeutics, Inc. | -10.35M |
| ACADIA Pharmaceuticals, Inc. | 100.78M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 21.15M |
| Cash from Financing (Quarterly) | 0.676M |
| Free Cash Flow | -93.90M |
| Free Cash Flow Per Share (Quarterly) | -0.3276 |
| Free Cash Flow to Equity (Quarterly) | -22.94M |
| Free Cash Flow to Firm (Quarterly) | -24.41M |
| Free Cash Flow Yield | -45.68% |